Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer

Overview of attention for article published in Lung Cancer: Targets and Therapy, October 2011

Altmetric Badge

About this Attention Score

Among the highest-scoring outputs from this source (#43 of 128)
Average Attention Score compared to outputs of the same age

Mentioned by

patent: 5 patents

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 31 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 20 publications that cite this research output.

20

The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.

Combining Nimotuzumab With Chemotherapy for Patients With Locally Advanced and Intermediate-Stage Nasopharyngeal Cancer: A Retrospective Comparison Study Using Five-Year, Real-World Survival Data

Article in Cureus (November 2023)

An EGCG Derivative in Combination with Nimotuzumab for the Treatment of Wild-Type EGFR NSCLC

Article in International Journal of Molecular Sciences (September 2023)

Antitumor effects of erlotinib in combination with berberine in A431 cells

Article in BMC Pharmacology and Toxicology (May 2023)